![Martin Ostrowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Ostrowski
Hoofd Techniek/Wetenschap/O&O bij Ryne Biotechnology, Inc.
Oorsprong van het eerstegraads netwerk van Martin Ostrowski
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts.
6
| Private Company | Investment Managers | 6 |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development.
1
| Holding Company | Biotechnology | 1 |
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI.
1
| Holding Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Martin Ostrowski via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Ladenburg Thalmann & Co., Inc. (Broker)
![]() Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Investment Banks/Brokers | Chief Executive Officer | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
McGill University | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Undergraduate Degree | |
Athabasca University | College/University | Undergraduate Degree | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Kyushu University | College/University | Doctorate Degree | |
Ladenburg Thalmann & Co., Inc.
![]() Ladenburg Thalmann & Co., Inc. Regional BanksFinance Ladenburg Thalmann & Co., Inc. provides investment baking and brokerage services. The firm also provides asset and wealth management, underwriting, alternative investments and advisory services. It serves emerging growth companies and high net worth individuals. The company was founded in 1876 and is headquartered in New York, NY. | Regional Banks | Chief Executive Officer | |
University of Stellenbosch | College/University | Undergraduate Degree | |
Tokyo Institute of Technology | College/University | Doctorate Degree | |
Genome Canada
![]() Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
ATHERSYS, INC. | Biotechnology | Director/Board Member | |
Goldman Sachs (Asia) LLC
![]() Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments. | Investment Banks/Brokers | Private Equity Investor | |
Aqumen Biopharmaceuticals KK
![]() Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Pharmaceuticals: Major | Chief Executive Officer | |
Goldman Sachs (Cayman) Trust Ltd.
![]() Goldman Sachs (Cayman) Trust Ltd. Investment Banks/BrokersFinance Part of The Goldman Sachs Group, Inc., Goldman Sachs (Cayman) Trust Ltd. is a Caymanian company that provides security brokerage services. The company is based in George Town, Cayman Islands. | Investment Banks/Brokers | Private Equity Investor | |
Nezu Asia Capital Management Ltd.
![]() Nezu Asia Capital Management Ltd. Investment ManagersFinance Nezu Asia Capital Management Ltd. (Nezu HK) is the alternative investment management subsidiary of Nezu Group S.A.R.L., itself owned by Nezu Group LP in the US. Headquartered in Hong Kong, Nezu HK was founded in 2004 and they provide discretionary investment advisory services to separately managed accounts and a private investment fund, which is open only to certain financially sophisticated and high-net worth individuals and entities. | Investment Managers | Chief Operating Officer Director of Finance/CFO | |
GlaxoSmithkline AB
![]() GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a company that manufactures pharmaceutical products. GlaxoSmithKline AB is based in Solna, Sweden. Founded in 1983. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Geistlich Biomaterials Vertriebsgesellschaft mbH
![]() Geistlich Biomaterials Vertriebsgesellschaft mbH Medical/Nursing ServicesHealth Services Geistlich Biomaterials Vertriebsgesellschaft mbH provides natural biomaterials for dental, medical and cosmetic surgery use. The company was founded in 1996 and is headquartered in Baden-Baden, Germany. | Medical/Nursing Services | Consultant / Advisor | |
John Molson School of Business | College/University | Masters Business Admin | |
The Royal College of Surgeons of England | College/University | Doctorate Degree | |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Nezu Asia Capital Management (Singapore) Pte Ltd.
![]() Nezu Asia Capital Management (Singapore) Pte Ltd. Investment ManagersFinance Nezu Asia Capital Management (Singapore) Pte Ltd. (Nezu Asia SG) is an independent hedge fund manager headquartered in Singapore. Nezu Asia SG manages long/short equity portfolios. | Investment Managers | President | |
XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Insitut de Recherche en Immunologie et en Cancérologie
![]() Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Consultant / Advisor | |
HEALIOS K.K. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Private Equity Investor | |
Alberta School of Business | College/University | Undergraduate Degree | |
Kagimoto Holdings KK | President | ||
Sighregen Co., Ltd. | President | ||
Nezu Master Strategy Feeder Ltd.
![]() Nezu Master Strategy Feeder Ltd. Investment Trusts/Mutual FundsMiscellaneous Nezu Master Strategy Feeder Ltd. Operates as a private equity fund. The company is headquartered in Grand Cayman, Cayman Islands. | Investment Trusts/Mutual Funds | Director/Board Member | |
Sven Kili Consulting Ltd. | Chairman | ||
Redona Therapeutics, Inc.
![]() Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Antion Biosciences SA
![]() Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Biotechnology | Chief Executive Officer | |
United Immunity Co. Ltd.
![]() United Immunity Co. Ltd. Pharmaceuticals: MajorHealth Technology United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages. | Pharmaceuticals: Major | Director/Board Member | |
Standards Coordinating Body | Director/Board Member | ||
Healios N.A., Inc. | President Chief Executive Officer | ||
Catamaran Bio, Inc.
![]() Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Director/Board Member | |
PEAK BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
PowerX, Inc.
![]() PowerX, Inc. Miscellaneous Commercial ServicesCommercial Services PowerX, Inc. is a Japanese next-generation energy company that aims to build a new energy grid of renewable energy storage. The company is based in Minato-ku, Japan, and the CEO of the company is Masahiro Ito. The company will construct a large-scale storage battery factory to manufacture and sell battery products that realize the explosive spread of natural energy. The PowerX ship battery is a safe and secure product that uses LFP, which is a safe and long-life battery. The battery can be installed in racks and provided as a large-capacity type of the industry-standard 10 or 20ft container type. With PowerX's large industrial storage battery mega power, businesses can significantly reduce their electricity bills. The company's solution can be introduced right now and will be available for shipping from 2023. | Miscellaneous Commercial Services | Chairman |
Statistieken
Internationaal
Verenigde Staten | 18 |
Japan | 10 |
Canada | 8 |
Hongkong | 3 |
Kaaimaneilanden | 3 |
Sectoraal
Health Technology | 15 |
Finance | 11 |
Consumer Services | 11 |
Commercial Services | 5 |
Health Services | 2 |
Operationeel
Director/Board Member | 27 |
President | 9 |
Chief Executive Officer | 8 |
Undergraduate Degree | 7 |
Private Equity Investor | 7 |
Sterkste connecties
Insiders | |
---|---|
Sven Kili | 11 |
Hikaru Saito | 10 |
Hardy Kagimoto | 9 |
Jonathan Yeh | 8 |
Richard Kincaid | 7 |
David Rosenberg | 7 |
Darren Winia | 6 |
- Beurs
- Insiders
- Martin Ostrowski
- Bedrijfsconnecties